BARROW ROBERT (Chief Executive Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2026ACC: 0001193125-26-389887
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+750K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
750K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+750K
Price / share
—
Trade value
—
% of position
50.2%
9/14/2026
1.49M→2.24M
Total
Net shares
+750K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/14/2026 | A · Award | +750K | — | — | 50.2% | 1.49M | 2.24M |
| Total | +750K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported